AU2003225057A1 - Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens - Google Patents

Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens

Info

Publication number: AU2003225057A1
Authority: AU; Australia
Prior art keywords: formaldehyde; stabilize; release; control; polymer compositions
Prior art date: 2002-04-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003225057A

Inventor

Wenlei Jiang

Steven P. Schwendeman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Michigan

Original Assignee

University of Michigan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-19

Filing date

2003-04-18

Publication date

2003-11-03

2003-04-18 Application filed by University of Michigan filed Critical University of Michigan

2003-11-03 Publication of AU2003225057A1 publication Critical patent/AU2003225057A1/en

Status Abandoned legal-status Critical Current

Links

WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 title 3
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229920000642 polymer Polymers 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Immunology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2003225057A 2002-04-19 2003-04-18 Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens Abandoned AU2003225057A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US37385802P	2002-04-19	2002-04-19
US60/373,858		2002-04-19
PCT/US2003/012032 WO2003088946A1 (en)	2002-04-19	2003-04-18	Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens

Publications (1)

Publication Number	Publication Date
AU2003225057A1 true AU2003225057A1 (en)	2003-11-03

Family

ID=29251095

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003225057A Abandoned AU2003225057A1 (en)	2002-04-19	2003-04-18	Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens

Country Status (2)

Country	Link
AU (1)	AU2003225057A1 (en)
WO (1)	WO2003088946A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007533634A (en) *	2003-09-30	2007-11-22	アキュスフィア，インコーポレイテッド	Sustained release pharmaceutical formulation for injection, oral or topical use
KR101679812B1 (en) *	2007-09-14	2016-11-28	사노피 파스테르 바이오로직스, 엘엘씨	Pharmaceutical compositions containing clostridium difficile toxoids a and b
CN101972477B (en) *	2010-10-21	2012-09-26	中国医学科学院医学生物学研究所	Zinc phosphate vaccine adjuvant
GB2498112A (en) *	2011-11-11	2013-07-03	Novartis Ag	Preparation of a diphtheria toxoid by incubating toxin concentrate with an amino acid and formaldehyde
GB2495341B (en) *	2011-11-11	2013-09-18	Novartis Ag	Fermentation methods and their products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU490824A1 (en) *	1974-08-27	1975-11-05	Институт полиомиелита и вирусных энцефалитов АМН СССР	Method of inactivating infectiousness of viruses
FR2505657A1 (en) *	1981-05-13	1982-11-19	Pasteur Institut	IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
JPS60193925A (en) *	1984-03-13	1985-10-02	Chemo Sero Therapeut Res Inst	Lyophilized pharmaceutical preparation vaccine
DK0487632T3 (en) *	1989-08-15	1998-05-25	Massachusetts Inst Technology	Stabilized vaccine compositions
FR2742756B1 (en) *	1995-12-22	1998-04-03	Pasteur Merieux Serums Vacc	STABILIZERS FOR LIVE VACCINES, VACCINES CONTAINING SAME, AND PROCESSES FOR THEIR PREPARATION

2003
- 2003-04-18 WO PCT/US2003/012032 patent/WO2003088946A1/en not_active Application Discontinuation
- 2003-04-18 AU AU2003225057A patent/AU2003225057A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003088946A1 (en)	2003-10-30

Similar Documents

Publication	Publication Date	Title
AU2003212437A1 (en)	2003-09-29	Methods, devices, and articles for controlling the release of volatile materials
AU2003235707A1 (en)	2003-07-30	Immunogenic preparations and vaccines on the basis of mrna
AU2001255196A1 (en)	2001-10-08	Compositions and methods for enhancing immunogenicity of antigens
AU2002357643A1 (en)	2003-04-14	The human mob-5 (il-24) receptors and uses thereof
AU2003270779A1 (en)	2004-04-08	Vaccine compositions and adjuvant
AU2003293644A1 (en)	2004-05-25	Moldings and preparation and uses thereof
AU2002326751A1 (en)	2003-03-03	Immunoglobulin e vaccines and methods of use thereof
AU2002354219A1 (en)	2003-06-30	Composition for friction material and friction material using the composition
AU2002309486A1 (en)	2002-10-15	Methods and compositions for modulating the immune system of animals
AU2003224313A1 (en)	2003-11-17	Mycobacterial antigens and uses thereof
AU2002351388A1 (en)	2003-06-30	Methods and compositions for controlled release of drugs
AU2002344382A1 (en)	2002-12-16	Release regulating silicone system and use thereof for preparing curable release compositions
AU2002307971A1 (en)	2003-04-10	Vaccine against the nile fever virus
AU2003225057A1 (en)	2003-11-03	Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
AU2002212049A1 (en)	2003-05-15	Novel silicone material, its preparation method and the use thereof
AU2003267361A1 (en)	2004-04-30	Orthopoxvirus antigens and use thereof
AU2002347464A1 (en)	2003-01-02	Anti-arthropod vector vaccines methods of selecting and uses thereof
WO2002076384A3 (en)	2003-05-01	Therapeutic compositions that alter the immune response
AU2003276844A1 (en)	2004-03-19	Formulations of modified antibodies and methods of making the same
AU2002359792A1 (en)	2003-06-30	Methods and compositions for the inhibition of viral release
AU2002365136A1 (en)	2003-07-30	Compositions and methods for controlled release
AU2002320079A1 (en)	2002-12-23	Vaccines, immunotherapeutics and methods of using the same
AU2002342949A1 (en)	2003-06-19	Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other
AU2002325783A1 (en)	2003-05-22	Vaccine formulation potentiated by the combination of a DNA and an antigen
AU2002248646A1 (en)	2002-10-03	Compositions and methods for modulating an immune response

Legal Events

Date	Code	Title	Description
2005-01-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase